Guru Ownership Trend
Guru Analysis for CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics AG (CRSP), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $498.75 M.
Top institutional holders include Catherine Wood and Ken Fisher.
Institutional sentiment is currently Bearish. This is evidenced by a $95.21 M net outflow during the quarter.
Recent activity highlights Ken Fisher who opened a new position. Conversely, Catherine Wood reduced exposure by 16.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for CRISPR Therapeutics AG (CRSP)
Major holders include Catherine Wood ($516 M), Ken Fisher ($4.25 M), Paul Tudor Jones ($2.32 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 9.64 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $95.21 M, with 3 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 0 fully exited CRSP. The total reported sell value was $101.12 M.
Yes, 2 managers opened new positions in CRSP, and 1 increased their existing holdings. The total reported buy value was $5.91 M.